{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"News | Checkpoint inhibitors and COVID-19 mortality; HCC rates slow in cities, continue to climb in rural areas","description":"Blood &amp;amp; Cancer News Stories:&amp;nbsp;  Immune checkpoint inhibitors don\u2019t increase COVID-19 incidence or mortality, studies suggest: https:\/\/bit.ly\/2JlP2FN HCC rates slow in cities, continue to climb in rural areas: https:\/\/bit.ly\/2Jx6Ux1 Risk factors for severe immune-related AEs identified: https:\/\/bit.ly\/3fO6Fd8  Contact Blood &amp;amp; Cancer at podcasts@mdedge.com &amp;nbsp; ","author_name":"Blood &amp; Cancer","author_url":"https:\/\/www.mdedge.com\/podcasts\/blood-cancer","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/16998680\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/984545\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/16998680"}